Navigation Links
Bone Therapy May Not Always Need Monitoring
Date:6/24/2009

In older women, annual measurements are unnecessary, study finds

WEDNESDAY, June 24 (HealthDay News) -- Monitoring bone density in older women after they've started taking drugs to prevent osteoporosis is unnecessary and could be potentially misleading, researchers say.

In the study, Australian researchers analyzed data from a large randomized trial that compared the effects of the drug alendronate (a widely used bisphosphonate) in more than 6,000 postmenopausal women with low bone mineral density, which is a risk factor for fractures.

The women's bone density was measured at the start of the study and again one, two and three years later. After three years of treatment, 97.5 percent of the women who took the drug showed at least a modest increase in bone density, and there was little variation in the treatment effect between individuals, the researchers found.

The findings, which appear online June 24 in BMJ, suggest that monitoring a person's response during the first three years of the treatment is unnecessary and, because of the potential to mislead, should not be done, concluded the researchers, from the School of Public Health at the University of Sydney.

The results support the case against routine monitoring during the early years of treatment, according to an accompanying editorial by Juliet Compston, professor of bone medicine at the University of Cambridge, in England. She said that when changes in bone mineral density are used to monitor treatment, people may be given inappropriate advice.

"Routine monitoring of bone mineral density during the first few years of antiresorptive treatment cannot be justified because it may mislead patients, lead to inappropriate management decisions and waste scarce health care resources," she concluded.

More information

The U.S. National Institute of Arthritis and Musculoskeletal and Skin Diseases offers tips on bone health for life.



-- Robert Preidt



SOURCE: BMJ, news release, June 23, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Dynatronics Begins Shipping New V-Force Vibration Therapy Units
2. Biomarkers predict brain tumors response to therapy
3. Determining Who Will Respond to Brain Tumor Therapy
4. Promising Therapy for Prostate Cancer
5. AthletiCo Opens 52nd Physical Therapy Center in South Elgin
6. Platelet Rich Plasma Therapy (PRP) Accelerates Healing of Joint Injuries, Osteoarthritis Pain
7. US Brachytherapy Market to Reach $1.6 Billion by 2015, According to New Report by Global Industry Analysts, Inc.
8. Video: New Biological Therapy Ilaris(R) Approved in US to Treat Children and Adults with CAPS, a Serious Life-Long Auto-Inflammatory Disease
9. Varians RapidArc Radiotherapy Technology Enables Pioneering Cancer Treatments at Top Dutch Oncology Center
10. Prostate Cancer Patient Receives First RapidArc Radiotherapy Treatment at Major Danish Hospital
11. Spinal Decompression Therapy Offers Hope for Back Pain
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Bone Therapy May Not Always Need Monitoring 
(Date:1/13/2017)... ... January 13, 2017 , ... The 18th European Congress: Perspectives in Lung Cancer ... 2017. This Congress is expertly designed to meet the educational needs of European ... cancer. , Chaired by Dr. Giorgio V. Scagliotti, Professor of Oncology at the University ...
(Date:1/13/2017)... ... January 13, 2017 , ... KOAMTAC ®, Inc., a leading ... the next generation companion scanner and data collector at the National Retail Federation’s Big ... created as an answer to the market’s need for more compact and rugged devices ...
(Date:1/13/2017)... ... ... inventor from Pahrump, Nev., used an unsavory medical experience to think of a way to ... urine bag for a half year due to lazy bladder," he said. "Keeping these things ... better way to do this." , He then designed and created a prototype of the ...
(Date:1/13/2017)... ... ... People who have sensitive teeth are about as common as those who do ... dental hygiene products in the market contain chemical ingredients that only aggravate the condition ... oral care routine to keep their teeth white and healthy is a struggle with ...
(Date:1/13/2017)... Okla. (PRWEB) , ... January 13, 2017 , ... Friday, ... the area of the game room, increasing the size of the location to 90,000 ... Course, an 8-hole mini golf course that takes customers on an educational tour of ...
Breaking Medicine News(10 mins):
(Date:1/12/2017)...   TyrNovo , s NT219 ... cancer drug resistance and would ...   NT219 is a novel proprietary ... oncogenic pathways ( IRS1/2 and STAT3) highly ... the tumor .   NT219 has ...
(Date:1/12/2017)... 2017 This new report from VPGMarketResearch contains ... of the German hospital microbiology testing market, including:  ... hospital laboratory practice, as well as key economic, regulatory, ... during the next ten years.  ... and etiology of major infectious diseases and microorganisms.  ...
(Date:1/12/2017)... -- Harrington Discovery Institute at University Hospitals in ... Drug Discovery Foundation (ADDF) have expanded their collaboration ... Alzheimer,s disease. Together, the two organizations will jointly ... academic researchers. By leveraging their combined expertise, investment, ... will advance Alzheimer,s disease drug discovery projects of ...
Breaking Medicine Technology: